enVVeno Medical Corp SEC filings NVNO

enVVeno Medical Corp has 415 filings in SEC EDGAR's recent list, going back to Dec 15, 2015. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

enVVeno Medical Corp SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Oct 29, 2026 —
DEF 14A Proxy statement Oct 29, 2026 Dec 10, 2026
DEFA14A Additional proxy material Oct 30, 2025 —
DEF 14A Proxy statement Oct 30, 2025 Dec 11, 2025
DEF 14A Proxy statement Nov 19, 2024 Dec 18, 2024
DEF 14A Proxy statement Nov 3, 2023 Nov 3, 2023
DEF 14A Proxy statement Nov 1, 2022 Nov 1, 2022
DEF 14A Proxy statement Nov 2, 2021 Nov 1, 2021
DEF 14A Proxy statement Nov 13, 2020 Nov 13, 2020
DEFA14A Additional proxy material Aug 19, 2020 —
DEF 14A Proxy statement Aug 12, 2020 Aug 12, 2020
PRE 14A Preliminary proxy statement Jul 24, 2020 Jul 23, 2020
DEF 14A Proxy statement Oct 29, 2019 Oct 28, 2019
DEF 14A Proxy statement Nov 28, 2018 Nov 28, 2018

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NVNO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1661053
Former names
Hancock Jaffe Laboratories, Inc. (until Sep 22, 2021)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.